-
Biothera Appoints CFO
contractpharma
May 22, 2018
Andrew D.C. LaFrence, CPA has been appointed senior vice president and chief financial officer, effective May 29, of Biothera Pharmaceuticals, a clinical stage immuno-oncology company.
-
GSK’s CFO chooses to exit company
pharmafile
May 10, 2018
Simon Dingemans has been Chief Financial Officer at GSK since 2011 but has now chosen to retire from the position this time next year.
-
CE Mark for Implandata's EYEMATE™ System for Improved Monitoring and Management of Glaucoma Patients
b3cnewswire
June 01, 2017
apceth Biopharma GmbH, a cell therapy company with a proprietary portfolio of genetically modified mesenchymal stem cell therapeutics for the treatment of inflammatory diseases and cancer.
-
Eagle Pharmaceuticals Appoints New CFO
americanpharmaceuticalreview
May 17, 2017
Eagle Pharmaceuticals announced Pete A. Meyers has joined the Company as Chief Financial Officer. Meyers will also serve as the company’s principal financial officer and principal accounting officer.
-
Reinhard Kandera Appointed Chief Financial Officer of Hookipa Biotech
b3cnewswire
April 20, 2017
Hookipa Biotech AG, a company pioneering a new class of immunotherapies for oncology and infectious diseases, today announces that Reinhard Kandera has joined the Company as Chief Financial Officer (CFO).
-
Amyris Names Kathleen Valiasek CFO
contractpharma
January 09, 2017
Senior finance and business veteran with Fortune 500 experience joins company.